Novogene is a genomic services and solutions
provider with cutting edge NGS and bioinformatics
expertise, and the largest sequencing capacities in...
the world. The company utilizes scientific expertise,
a commitment to customer service and unsurpassed
data See More
provider with cutting edge NGS and bioinformatics
expertise, and the largest sequencing capacities in...
the world. The company utilizes scientific expertise,
a commitment to customer service and unsurpassed
data See More
Location: China, Beijing, Chaoyang District
Employees: 1001-5000
Phone: +1 916-252-0068
Total raised: $75M
Founded date: 2011
Investors 1
| Date | Name | Website |
| - | SDIC Fund ... | sdicfund.c... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 30.11.2016 | Series B | $75M | - |
Mentions in press and media 15
| Date | Title | Description |
| 28.08.2026 | Global genomics and multi-omics leader Novogene to establish its first Australian laboratory at Cabrini Health, accelerating access to precision cancer care | MELBOURNE, Australia, Aug. 28, 2026 /PRNewswire/ -- Global multi-omics leader Novogene is establishing its first Australian laboratory at Cabrini Health, bringing advanced genomic capabilities closer to Australian patients and researchers, ... |
| 27.07.2026 | Novogene Europe expands single-cell sequencing capability at Cambridge Omics Centre | Offers UK academic, biotech and biopharma researchers direct access to specialist project support, 10x Genomics Chromium Single Cell-based workflows, sequencing infrastructure and bioinformatics expertise Cambridge, UK, 27 July 2026: Novoge... |
| 13.07.2026 | Novogene Europe launches Untargeted Metabolomics Service at Cambridge Omics Centre | • Strengthens multiomics portfolio offering metabolite-level insight to connect molecular data with biological function across broader life science studies • New workflow built around Thermo Scientific Vanquish UHPLC coupled with Orbitrap E... |
| 20.06.2026 | Statement on Novogene Erroneously Listed on 1260H List | BEIJING, June 20, 2026 /PRNewswire/ -- On June 8, 2026, the U.S. Department of Defense (DOD) erroneously designated Novogene Co., Ltd. on its Section 1260H list under the National Defense Authorization Act for Fiscal Year 2021. This designa... |
| 11.09.2025 | China’s Domestic Sequencers Take Bigger Market Share in First Half After Illumina Import Ban | (Yicai) Sept. 11 -- The Chinese market share of domestically made genome-sequencing products has increased in the first half of the year, as the country imposed an import ban on US gene-sequencing equipment giant Illumina early this year. A... |
| 23.06.2025 | Novogene Establishes New Subsidiary in Korea to Accelerate Multi-Omics Research | SEOUL, South Korea, June 23, 2025 /PRNewswire/ -- Novogene, a global leader in next-generation sequencing (NGS) and multi-omics solutions, today announced the establishment ofNovogene Korea Limited, a wholly owned subsidiary headquartered i... |
| 05.06.2025 | Novogene Certified for Olink® Services Across Multiple Labs; Expands Proteomics Portfolio with Olink® Reveal | SINGAPORE, June 5, 2025 /PRNewswire/ -- Novogene, a global leader in multi-omics solutions, is proud to announce its designation as an Olink® Certified Service Provider (CSP) across multiple laboratories worldwide. This milestone positions ... |
| 20.02.2025 | Chinese Rivals Seize on Illumina’s Blacklisting to Woo Clients | (Bloomberg) -- Beijing’s surprise move to blacklist Illumina Inc. has unleashed a frenzy among the US firm’s Chinese rivals to win market share from the gene-sequencing giant. While Illumina is still assessing the consequences of being adde... |
| 03.09.2024 | Next Generation Sequencing Market is poised to grow from USD 36.04 billion by 2031: Skyquest Technology | Share Tweet Share Share Email In recent years, next generation sequencing is a technique that employs massive parallelism in sequencing millions or even billions of DNA strands. This method is also known as high throughput sequencing. NGS i... |
| 07.05.2024 | NovogeneAIT Collaborates with A*STAR’s Institute of Molecular and Cell Biology on Spatial Transcriptomics Technology | SINGAPORE, May 7, 2024 /EINPresswire.com/ -- NovogeneAIT Genomics Singapore (“NovogeneAIT”) has entered into a research collaboration with A*STAR’s Institute of Molecular and Cell Biology (IMCB). This collaboration aims to elucidate the und... |
Show more